Insiders · Profile

Fenton Mary Kay

Chief Financial Officer at Cullinan Therapeutics. Filing since 20 Feb 2026. CIK 0001378589

Company

Date

Role

Action

Amount

Of holding

20 Feb 2026

Chief Financial Officer

Sold at will

4,398

$59.90K

3.4%

1 decision on file.